Comparative Effectiveness Of Second-Line (2L) Treatment (Rx) With Cabozantinib (Cabo) In Patients (Pts) With Metastatic Clear Cell Renal Cell Carcinoma (Mccrcc) After First-Line (1L) Rx With Ipilimumab + Nivolumab (Ipi+Nivo) Vs. Pd-1/L1 Inhibitor (Pdi) + Tyrosine Kinase Inhibitor (Tki)
Cabozantinib
Below is an instruction that describes a task, paired with an input that provides further context. Write a response that appropriately completes the request. ### Instruction: Identify all the mentioned drugs in the given text. Text may or may not contain drug. If they contain more than 1 drug, use ";" as delimiter and join them. ### Input: Comparative Effectiveness Of Second-Line (2L) Treatment (Rx) With Cabozantinib (Cabo) In Patients (Pts) With Metastatic Clear Cell Renal Cell Carcinoma (Mccrcc) After First-Line (1L) Rx With Ipilimumab + Nivolumab (Ipi+Nivo) Vs. Pd-1/L1 Inhibitor (Pdi) + Tyrosine Kinase Inhibitor (Tki) ### Output: Cabozantinib